Balyasny Asset Management
AGN

Balyasny Asset Management’s Allergan plc AGN Stock Holding History

Balyasny Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-175,000
Closed -$22.9M – 1772
2019
Q2 		$22.9M Buy
175,000
+125,000
+250% +$17.3M 0.15% 199
2019
Q1 		$7.32M Buy
50,000
+2,000
+4% +$290K 0.05% 470
2018
Q4 		$6.42M Buy
+48,000
New +$7.87M 0.05% 456
2018
Q2 		– Sell
-75,000
Closed -$12.6M – 2325
2018
Q1 		$12.6M Buy
+75,000
New +$12.6M 0.05% 459
2015
Q4 		– Sell
-20,000
Closed -$5.44M – 1539
2015
Q3 		$5.44M Buy
+20,000
New +$6.14M 0.04% 503
2015
Q2 		– Sell
-30,000
Closed -$8.93M – 1414
2015
Q1 		$8.93M Buy
+30,000
New +$8.55M 0.07% 361

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Balyasny Asset Management's AGN Position: Q2 2020 in Review

Balyasny Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 521,560 shares — an estimated $92.4M sold.

Balyasny Asset Management first reported a position in AGN in Q2 2013 and held it in 25 quarters. The position peaked at $118M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Balyasny Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Balyasny Asset Management sold 521,560 Allergan plc shares in Q2 2020, an estimated $92.4M.
  • Balyasny Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 25 quarters.
  • Balyasny Asset Management's Allergan plc position peaked at $118M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.